MYH2 and breast cancer: Furthermore, the discovery of certain proteins (MYH2, MYL1, MYL2, MYH7) and microRNAs (hsa-let-7d-5p) linked to the advancement of breast cancer offers new, prospective biomarkers for diagnosis and therapy, opening the door for innovative therapeutic approaches.